-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Bioforce Nanosciences Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2021 to Q3 2024.
- Bioforce Nanosciences Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 29.3M shares, unchanged year-over-year.
- Bioforce Nanosciences Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 29.3M shares, unchanged from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)